89bio Current Assets

89bio (ETNB) currently reports a current assets of $600M as of June 2025. That compares with $580M in the prior-year period — up 3.7% year over year. Use the charts on this page to explore 89bio's current assets history and peer comparisons.

89bio's current assets increased from $580M to $600M — a 3.7% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

89bio reported $600M in current assets as of June 2025. That compares with $580M in the prior-year period — up 3.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $600M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for 89bio, and consider following ETNB for alerts when major investors trade the stock.

89bio is classified in the Healthcare sector. On current assets, it currently shows $600M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ETNB with unrelated industries.